HealthcareServices

Intermittent Claudication Market Trends and Insights: Global Forecast to 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the intermittent claudication market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Intermittent Claudication Market size between 2026 and 2035?

The intermittent claudication market size has experienced strong growth in recent years. It is projected to expand from $13.51 billion in 2025 to $14.31 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to the rising prevalence of peripheral artery disease, an increasing aging population, a high incidence of smoking-related vascular disorders, the growing burden of cardiovascular disease, and the expanded availability of vascular intervention procedures.

The intermittent claudication market is forecast to undergo significant expansion over the next few years. It is expected to reach a value of $17.98 billion by 2030, with a compound annual growth rate (CAGR) of 5.9%. The projected increase in this period is driven by factors such as greater understanding of peripheral artery disease symptoms, an increasing need for minimally invasive vascular interventions, continuous progress in pharmacological treatments, the growing acceptance of home-based disease management strategies, and enhanced screening and diagnostic initiatives. Prominent developments anticipated in the forecast timeframe include a heightened focus on the early detection of peripheral artery disease, a rise in the application of combination drug therapies, an increasing preference for minimally invasive revascularization procedures, the expansion of supervised exercise therapy programs, and improved patient knowledge and disease management practices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22021&type=smp

Which Drivers Are Impacting Market Performance In The Intermittent Claudication Market?

The rising prevalence of peripheral artery disease (PAD) is anticipated to stimulate the expansion of the intermittent claudication market in the foreseeable future. Peripheral artery disease is characterized as a circulatory ailment where narrowed arteries decrease blood flow to the limbs, resulting in discomfort, numbness, and various complications. The escalating occurrences of peripheral artery disease are linked to factors such as an aging demographic, diabetes, smoking, hypertension, obesity, and inactive lifestyles. Peripheral artery disease (PAD) precipitates intermittent claudication by diminishing blood flow to the leg muscles during physical exertion, which leads to pain and cramping due to insufficient oxygen. For instance, in June 2023, as per the American Heart Association Journals, a US-based peer-reviewed open-access scientific journal, peripheral artery disease (PAD) impacts 7-12 million individuals in the U.S. and 200 million globally. Hence, the increasing instances of peripheral artery disease (PAD) are propelling the growth of the intermittent claudication market.

Which Segments Are Contributing To The Growth Of The Intermittent Claudication Market?

The intermittent claudication market covered in this report is segmented –

1) By Type: Medication Therapies, Revascularization

2) By Route Of Administration: Parenteral Route, Oral Route, Other Routes Of Administration

3) By Application: Hospitals, Clinics, Home Healthcare, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Medication Therapies: Antiplatelet Agents, Vasodilators, Phosphodiesterase Inhibitors, Cilostazol, Pentoxifylline

2) By Revascularization: Angioplasty, Stenting, Bypass Surgery, Endarterectomy

What Industry Trends Are Transforming The Intermittent Claudication Market?

Leading companies in the Intermittent Claudication market are increasingly adopting minimally invasive endovascular innovations, such as percutaneous bypass systems, with the goal of improving treatment efficiency, procedural success, and patient outcomes. These percutaneous bypass systems are advanced vascular technologies that establish an endovascular bypass pathway utilizing specialized stent grafts and catheters. Their capabilities include restoring blood flow across extensive arterial blockages, reducing the need for open surgical bypass, and supporting faster patient recovery. As an illustration, in June 2023, Endologix LLC, a US-based medical device company focused on vascular disease therapies, secured FDA approval for its DETOUR System. This system is a minimally invasive percutaneous bypass solution designed to address long, complex superficial femoropopliteal lesions in patients with peripheral artery disease (PAD). The DETOUR System integrates the TORUS stent graft platform, a novel endovascular bypass technique, and possesses the capability to manage long-segment occlusions, thereby enabling effective treatment for challenging femoropopliteal blockages. Ultimately, the DETOUR System enhances blood flow restoration, decreases procedural morbidity, and expands the available treatment options for patients suffering from symptomatic PAD and intermittent claudication.

Who Are The Prominent Global Companies Shaping The Intermittent Claudication Market Landscape?

Major companies operating in the intermittent claudication market are Pfizer Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, Teva Pharmaceutical, Otsuka Pharmaceutical Co. Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories, Alkem Laboratories, Aastrid Life Sciences Pvt. Ltd., Manus Aktteva Biopharma LLP, Enomark Pharma.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intermittent-claudication-global-market-report

Which Region Is Projected To Lead The Intermittent Claudication Market During The Forecast Period?

North America was the largest region in the intermittent claudication market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intermittent claudication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intermittent Claudication Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22021&type=smp

Browse Through More Reports Similar to the Global Intermittent Claudication Market 2026, By The Business Research Company

Hearing Loop Market Report 2026

https://www.thebusinessresearchcompany.com/report/hearing-loop-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Muscle Spasticity Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795